|
1
|
Cai J, Zhang R. Molecular Structure and Supramolecular Architecture of Brivanib: (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f] [1,2,4]triazin-6-yloxy)propan-2-ol. CRYSTALLOGR REP+ 2022. [DOI: 10.1134/s1063774522070045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
|
2
|
Morris G, Keogh AP, Farid U, Stumpf A. Development of an impurity and hydrate form controlling continuous crystallization to telescope a two-step batch recrystallization in the GDC-4379 drug substance process. Chem Eng Res Des 2022. [DOI: 10.1016/j.cherd.2022.02.022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
|
3
|
Cheng K, Liu CF, Rao GW. Anti-angiogenic Agents: A Review on Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Inhibitors. Curr Med Chem 2021; 28:2540-2564. [PMID: 32407259 DOI: 10.2174/0929867327666200514082425] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2020] [Revised: 04/18/2020] [Accepted: 04/23/2020] [Indexed: 11/22/2022]
Abstract
Tumor growth inhibition can be achieved by inhibiting angiogenesis, which has been a field of great concern in recent years. Important targets to inhibit angiogenesis include vascular endothelial growth factor receptor (VEGFR) and its homologous tyrosine kinase receptor. Anti-angiogenic therapy based on inhibition of VEGFR-2 is an effective clinical treatment strategy. The research progress of VEGFR-2 inhibitors is reviewed in this paper from the aspects of drug development and chemical synthesis.
Collapse
Affiliation(s)
- Kang Cheng
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China
| | - Chen-Fu Liu
- School of Pharmaceutical Sciences, Gannan Medical University, Ganzhou 341000, China
| | - Guo-Wu Rao
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China
| |
Collapse
|
|
4
|
Mohammed AQ, Sunkari PK, Mohammed AB, Srinivas P, Roy AK. Quality by Design in Action 2: Controlling Critical Material Attributes during the Synthesis of an Active Pharmaceutical Ingredient. Org Process Res Dev 2015. [DOI: 10.1021/op500297g] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Abdul Qayum Mohammed
- CTO-III, Dr. Reddy’s Laboratories Ltd, Plot 116, 126C and Survey number
157, S.V. Co-operative Industrial
Estate, IDA Bollaram, Jinnaram Mandal, Medak District, Telangana 502325, India
- Department
of Chemistry, Osmania University, Hyderabad, Telangana 500007, India
| | - Phani Kiran Sunkari
- CTO-III, Dr. Reddy’s Laboratories Ltd, Plot 116, 126C and Survey number
157, S.V. Co-operative Industrial
Estate, IDA Bollaram, Jinnaram Mandal, Medak District, Telangana 502325, India
| | - Amjad Basha Mohammed
- Research
and Development, Integrated Product Development, Innovation Plaza, Dr. Reddy’s Laboratories Ltd, Bachupally, Qutubullapur Mandal, Rangareddy District, Telangana 500072, India
| | - P. Srinivas
- Department
of Chemistry, Osmania University, Hyderabad, Telangana 500007, India
| | - Amrendra Kumar Roy
- CTO-III, Dr. Reddy’s Laboratories Ltd, Plot 116, 126C and Survey number
157, S.V. Co-operative Industrial
Estate, IDA Bollaram, Jinnaram Mandal, Medak District, Telangana 502325, India
| |
Collapse
|
|
5
|
Mohammed AQ, Sunkari PK, Srinivas P, Roy AK. Quality by Design in Action 1: Controlling Critical Quality Attributes of an Active Pharmaceutical Ingredient. Org Process Res Dev 2015. [DOI: 10.1021/op500295a] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Abdul Qayum Mohammed
- CTO-III, Dr. Reddy’s Laboratories Ltd, Plot 116, 126C and Survey number
157, S.V. Co-operative Industrial
Estate, IDA Bollaram, Jinnaram Mandal, Medak District, Telangana 502325, India
- Department
of Chemistry, Osmania University, Hyderabad, Telangana 500007, India
| | - Phani Kiran Sunkari
- CTO-III, Dr. Reddy’s Laboratories Ltd, Plot 116, 126C and Survey number
157, S.V. Co-operative Industrial
Estate, IDA Bollaram, Jinnaram Mandal, Medak District, Telangana 502325, India
| | - P. Srinivas
- Department
of Chemistry, Osmania University, Hyderabad, Telangana 500007, India
| | - Amrendra Kumar Roy
- CTO-III, Dr. Reddy’s Laboratories Ltd, Plot 116, 126C and Survey number
157, S.V. Co-operative Industrial
Estate, IDA Bollaram, Jinnaram Mandal, Medak District, Telangana 502325, India
| |
Collapse
|